The University of Chicago Header Logo

Connection

Richard A. Larson to Amyloidosis

Back to Details
This is a "connection" page, showing publications Richard A. Larson has written about Amyloidosis.
Richard A. Larson
Connection Strength
0.053
Amyloidosis
  1. Clinical efficacy of high-dose dexamethasone with maintenance dexamethasone/alpha interferon in patients with primary systemic amyloidosis: results of United States Intergroup Trial Southwest Oncology Group (SWOG) S9628. Blood. 2004 Dec 01; 104(12):3520-6.
    View in: PubMed
    Score: 0.053
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.